Abbott Freestyle Libre receives expanded coverage in Japan
By HME News Staff
Updated 10:25 AM CDT, Wed March 30, 2022
ABBOTT PARK, Ill. – Abbott has received approval from the Japanese Ministry of Health, Labour and Welfare for expansion of reimbursement coverage for its FreeStyle Libre system to include all people with diabetes who use insulin at least once a day. The expanded coverage will enable more people with diabetes to access the glucose data needed to manage their condition without the routine fingersticks associated with traditional blood glucose monitoring. "The best health care solution is the one that helps the most people, which is why we designed our FreeStyle Libre system with access and affordability in mind from the very beginning," said Jared Watkin, senior vice president of Abbott's diabetes care business. "FreeStyle Libre systems provide a complete and comprehensive glucose picture without the need for routine fingersticks. The technology helps enable behavior change, which ultimately helps people live better, fuller lives."
Comments